Partners

Private Companies:

biogen
ima
new England controls
Roche

 
 
 
 
 
 
 
 
 
 
 
 
 

Governmental Institutions:

NSF

 

US FDA
Emerging Technology Program

 
 
 
 
 
 
 

Pending authorization from other companies.